Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 13, 2014 - Issue 8
Submit an article Journal homepage
507
Views
9
CrossRef citations to date
0
Altmetric
Drug Safety Evaluations

Drug safety evaluation of alemtuzumab for multiple sclerosis

Mark WillisInstitute of Psychological Medicine and Clinical Neuroscience, Cardiff University School of Medicine, Cardiff, [email protected]
, BSc MB BCh &
Neil P RobertsonInstitute of Psychological Medicine and Clinical Neuroscience, Cardiff University School of Medicine, Cardiff, [email protected]
Pages 1115-1124 | Published online: 16 Jun 2014

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Dejan Jakimovski, Caila B Vaughn, Svetlana Eckert, Robert Zivadinov & Bianca Weinstock-Guttman. (2020) Long-term drug treatment in multiple sclerosis: safety success and concerns. Expert Opinion on Drug Safety 19:9, pages 1121-1142.
Read now
Saeed Taheri, Mohammad Ali Sahraian & Nazila Yousefi. (2019) Cost-effectiveness of alemtuzumab and natalizumab for relapsing-remitting multiple sclerosis treatment in Iran: decision analysis based on an indirect comparison. Journal of Medical Economics 22:1, pages 71-84.
Read now
Yara Dadalti Fragoso, Tarso Adoni, Andrea Anacleto, Joseph Bruno Bidin Brooks, Margarete de Jesus Carvalho, Rinaldo Claudino, Alfredo Damasceno, Maria Lucia Brito Ferreira, Paulo Diniz da Gama, Marcus Vinicus Magno Goncalves, Anderson Kuntz Grzesiuk, Andre Palma da Cunha Matta & Monica Fiuza Koncke Parolin. (2014) How do we manage and treat a patient with multiple sclerosis at risk of tuberculosis?. Expert Review of Neurotherapeutics 14:11, pages 1251-1260.
Read now

Articles from other publishers (5)

Stuart Cook, Thomas Leist, Giancarlo Comi, Xavier Montalban, Gavin Giovannoni, Axel Nolting, Christine Hicking, Andrew Galazka & Elke Sylvester. (2019) Safety of cladribine tablets in the treatment of patients with multiple sclerosis: An integrated analysis. Multiple Sclerosis and Related Disorders 29, pages 157-167.
Crossref
Olaf Stuve, Per Soelberg Soerensen, Thomas Leist, Gavin Giovannoni, Yann Hyvert, Doris Damian, Fernando Dangond & Ursula Boschert. (2019) Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markers. Therapeutic Advances in Neurological Disorders 12, pages 175628641985498.
Crossref
Lucia Montanelli, Salvatore Benvenga, Laszlo Hegedüs, Paolo Vitti, Francesco Latrofa & Leonidas H. Duntas. 2018. Thyroid Diseases. Thyroid Diseases 733 761 .
Lucia Montanelli, Salvatore Benvenga, Laszlo Hegedus, Paolo Vitti, Francesco Latrofa & Leonidas H. Duntas. 2017. Thyroid Diseases. Thyroid Diseases 1 29 .
Lokesh K. Jha & Sandeep Mukherjee. 2015. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions 461 470 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.